Inter Pharma Public : Resolution of the Extraordinary General Meeting of Shareholders No. 1/2022

-Translation-

IP_OCS/012/2022

July 20, 2022

Subject: Resolution of the Extraordinary General Meeting of Shareholders No. 1/2022

Attn: President

The Stock Exchange of Thailand

Inter Pharma Public Company Limited ("the Company") held the Extraordinary General Meeting of Shareholders No. 1/2022 on Wednesday, July 20, 2022 at 14.00 hours via electronic media (E-Meeting) only. The significant resolutions of the Meeting are as follows:

1. To certify the Minutes of the 2022 Annual General Meeting of Shareholders. This agenda was approved by majority votes of shareholders attend the meeting and casting their votes as follows:

Approved	141,204,473	Votes,	equivalent to	100.00%
Disapproved	0	Votes,	equivalent to	0.00%
Abstained	0	Votes,	equivalent to	0.00%

2. Approved the capital decrease of the Company's registered capital of 19,423,560 Baht from the registered capital of 1 7 8 ,0 3 9 ,7 5 5 Baht to 158,616,195 Baht by canceling 38,847,120 unpaid-up ordinary shares with a par value of 0.50 Baht per share, which is the remaining ordinary shares after the allocation to the existing shareholders in proportion to their respective shareholdings (Rights Offering) of 2,387 shares, and remaining from the reserve for the exercise of the warrants to purchase the Company's ordinary shares (IP-W1 ) of 4 ,7 7 4 shares and reserve for the capital increase under General Mandate of 38,839,959 shares, including to approve the amendment of the Company's Memorandum of Association article 4, to comply with the decrease of the registered capital. This agenda must be approved by a vote of not less than three-fourths of the total number of votes of shareholders attending the meeting who are entitled to votes as follows:

Approved	141,204,473	Votes,	equivalent to	100.00%
Disapproved	0	Votes,	equivalent to	0.00%
Abstained	0	Votes,	equivalent to	0.00%

3. Approved the issuance and offering of new ordinary shares to specific investors (Private Placement) of not exceeding 74,510,000 shares by issuing and offering newly issued ordinary shares to Innobic LL Holding Company Limited, which is an indirect subsidiary of PTT Public Company Limited, where PTT indirectly holds shares through a 100%. This agenda must be approved by a vote of not less than three-fourths of the total number of votes of shareholders attending the meeting who are entitled to votes and Shareholders who veto the decision are not more than 10% of the total number of votes of shareholders who attend the meeting as follows:

Approved	138,585,161	Votes,	equivalent to	98.1450%
Disapproved	2,619,312	Votes,	equivalent to	1.8550%
Abstained	0	Votes,	equivalent to	0.0000%

บริษัท อินเตอร์ ฟาร์มา จ(มหาชน)ากัด เลขที่140/9 อาคารไอทีเอฟ ชัน้ 9 ถนนสีลม แขวงสุริยวงศ์ เขตบางรัก กรุงเทพมหานคร10500 โทรศัพท์ 02-634-0225 แฟ็ กซ์ 02-634-0135www.interpharma.co.th

Inter Pharma Public Company Limited 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawongse, Bangrak, Bangkok 10500, Thailand. Tel. [phone] Fax [phone]www.interpharma.co.th

2

4. Approved the approve the allotment of newly issued ordinary shares under General Mandate in the number of not exceeding 38,839,959 shares at the par value of Baht 0.50 per share. This agenda must be approved by a vote of not less than three-fourths of the total number of votes of shareholders attending the meeting who are entitled to votes as follows:

Approved	130,168,144	Votes,	equivalent to	92.1842%
Disapproved	1,620,000	Votes,	equivalent to	1.1473%
Abstained	9,416,329	Votes,	equivalent to	6.6686%

5. Approved the increase of the Company's registered capital of 57,602,430.50 Baht from the former registered capital of 158,616,195 Baht to 216 ,218 ,625 . 50 Baht by issuing 115,204,861 newly issued ordinary shares with a par value of 0 . 5 0 Baht per share to allocate to a private placement of 74 ,510 ,000 shares and the additional reserve for the adjustment of the rights of the warrants to purchase ordinary shares of the Company No. 1 (IP-W1) of 1,854,902 shares and reserve for the capital increase under General Mandate of 38,839,959 shares, including to approve the amendment of the Company's Memorandum of Association article 4, to comply with the capital increase. This agenda must be approved by a vote of not less than three-fourths of the total number of votes of shareholders attending the meeting who are entitled to votes as follows:

Approved	127,542,832	Votes,	equivalent to	90.3249%
Disapproved	4,245,312	Votes,	equivalent to	3.0065%
Abstained	9,416,329	Votes,	equivalent to	6.6686%

6. approve the allocation of newly issued ordinary shares of not over 115,204,861 shares with a par value of 0.50 Baht per share to offering to the private placement of 74,510,000 shares, and additional reserve for the adjustment of the warrants to purchase the Company's ordinary shares (IP-W1) of 1,854,902 shares and reserve for General Mandate of 38,839,959 shares, with details as follows;

6.1 Approve the allocation of 7 4 ,5 1 0 ,0 0 0 newly issued ordinary shares at the offering price of 14 Baht per share, a total of 1,043 ,140,000 Baht for offering to Innobic LL Holding Company Limited, a private placement (PP). This agenda was approved by majority votes of shareholders attend the meeting and casting their votes and Shareholders who veto the decision are not more than 10% of the total number of votes of shareholders who attend the meeting as follows:

Approved	138,579,161	Votes,	equivalent to	98.1408%
Disapproved	2,625,312	Votes,	equivalent to	1.8592%
Abstained	0	Votes,	equivalent to	0.0000%

6.2 Approve the allocation of 1,854,902 newly issued ordinary shares with a par value of 0.50 Baht to reserve for the exercise of the warrants to purchase ordinary shares of the Company No. 1 (IP-W1) according to the terms and conditions on the rights and duties of the issuer and the holders of the warrants to purchase ordinary shares of the Company No. 1 (IP-W1) because the Company has adjusted the rights of the warrants to preserve the interests of the warrant holders not to be inferior. This agenda was approved by majority votes of shareholders attend the meeting and casting their votes as follows:

Approved	137,768,473	Votes,	equivalent to	97.5666%
Disapproved	3,436,000	Votes,	equivalent to	2.4334%
Abstained	0	Votes,	equivalent to	0.0000%

บริษัท อินเตอร์ ฟาร์มา จ(มหาชน)ากัด เลขที่140/9 อาคารไอทีเอฟ ชัน้ 9 ถนนสีลม แขวงสุริวงศ์ เขตบางรัก กรุงเทพมหานคร10500 โทรศัพท์ 02-634-0225 แฟ็ กซ์ 02-634-0135www.interpharma.co.thInter Pharma Public Company Limited 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawongse, Bangrak, Bangkok 10500, Thailand. Tel. [phone] Fax [phone]www.interpharma.co.th

3

6.3 Approve the allocation of not exceeding 38,839,959 newly issued ordinary shares with a par value of 0 . 5 0 Baht to reserve for the capital increase under General Mandate. This agenda was approved by majority votes of shareholders attend the meeting and casting their votes as follows:

Approved	130,168,144	Votes,	equivalent to	92.1842%
Disapproved	1,620,000	Votes,	equivalent to	1.1473%
Abstained	9,416,329	Votes,	equivalent to	6.6686%

7. Approved the increase in the number of directors and appointment 3 new directors, The Meeting resolved to elect each individual new director as follows:

1. Mrs. Apimon Posri		Director
Approved	141,201,833	Votes,	equivalent to	99.9982%
Disapproved	2,496	Votes,	equivalent to	0.0018%
Abstained	0	Votes,	equivalent to	0.0000%

*To vote in this agenda, there are 1 shareholder who has stakeholder, totaling 144 shares.

2.	Mrs. Nattarin	Polpuech	Director
	Approved	141,204,473	Votes,	equivalent to	100.00%
	Disapproved	0	Votes,	equivalent to	0.00%
	Abstained	0	Votes,	equivalent to	0.00%
3.	Ms. Chompunuch Meevang	Director
	Approved	141,201,473	Votes,	equivalent to	100.00%
	Disapproved	0	Votes,	equivalent to	0.00%
	Abstained		Votes,	equivalent to	0.00%

*To vote in this agenda, there are 1 shareholder who has stakeholder, totaling 3,000 shares.

Please be informed accordingly,

Your Sincerely,

Dr. Trinnawat Thanitnithiphan

Chief Executive Officer

บริษัท อินเตอร์ ฟาร์มา จ(มหาชน)ากัด เลขที่140/9 อาคารไอทีเอฟ ชัน้ 9 ถนนสีลม แขวงสุริวงศ์ เขตบางรัก กรุงเทพมหานคร10500 โทรศัพท์ 02-634-0225 แฟ็ กซ์ 02-634-0135www.interpharma.co.thInter Pharma Public Company Limited 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawongse, Bangrak, Bangkok 10500, Thailand. Tel. [phone] Fax [phone]www.interpharma.co.th